Company intelligence / Profile preview

Euroclone

Pero, Lombardy, Italyeuroclonegroup.it ↗
Ownership
Private
Employees
~90
Development stage
Commercial
01

Overview

Euroclone offers a broad portfolio of laboratory equipment and consumables supporting molecular biology, cell culture, genomics/proteomics/cytogenetics workflows. The company also develops diagnostic kits and has participated in the development/distribution of molecular assays with partners like BD. No clinical trial results as it does not develop drugs directly.

Modalities
ReagentDeviceSoftware
Industry
Molecular Diagnostics
02

Partnerships

BD/Becton Dickinson – co-development/distribution agreement for molecular diagnostic tests on the BD MAX system

Beyond the preview

Go deeper on Euroclone.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Euroclone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call